Research recommendation(s) from an individual piece of guidance
|Guidance:||Rheumatoid arthritis - adalimumab, etanercept and infliximab|
|Date issued:||October 2007|
Research recommendations coming out of this guidance
- There are a number of ongoing studies of etanercept, adalimumab and infliximab in people with [rheumatoid arthritis] (RA), including direct comparisons between...
- Further data collection [relating to the safety and efficacy of the use of tumour necrosis factor alpha (TNF-α) inhibitors] is recommended from the current cohort...
This page was last updated: 14 November 2013